Table 1.
Comparison of metabolic variables and presence of comorbid diseases between patients with and without ADL disability.
| Characteristic | Disability+ n = 40 | Disability− n = 158 | P Value |
|---|---|---|---|
| Sex | |||
| M (%) | 11 (27.5) | 68 (43.0) | 0.073a |
| F (%) | 29 (72.5) | 90 (57.0) | |
| Age, median (IQR), yrs | 83.0 (78.8–86.0) | 76.5 (74.0–81.0) | <0.001b |
| Body mass index, mean (SD) | 20.7 (4.8) | 23.8 (3.6) | <0.001c |
| HbA1c, median (IQR), % | 6.0 (5.6–7.0) | 6.9 (6.4–7.5) | 0.005b |
| Bilirubin, median (IQR), mg/dL | 0.3 (0.2–0.4) | 0.5 (0.4–0.7) | <0.001b |
| RBC count (x1012/L) (SD) | 3.54 (0.65) | 4.28 (0.52) | <0.001c |
| Hypertension | |||
| − (%) | 7 (17.5) | (31.6) | 0.078a |
| + (%) | 33 (82.5) | 141 (68.4) | |
| Hyperlipidemia | |||
| − (%) | 18 (45.0) | 56 (35.4) | <0.001a |
| + (%) | 22 (55.0) | 102 (64.6) | |
| Coronary artery disease | |||
| − (%) | 27 (67.5) | (74.7) | 0.238a |
| + (%) | 13 (32.5) | 50 (25.3) | |
| Cerebrovascular disease | |||
| − (%) | 28 (30.0) | (91.8) | <0.001a |
| + (%) | 12 (70.0) | 13 (8.2) | |
| Retinopathy | |||
| − (%) | 7 (21.2) | 101 (76.4) | <0.001a |
| Simple (%) | 2 (6.1) | 13 (10.6) | 0.2177a |
| Proliferative (%) | 24 (72.7) | 16 (13.0) | <0.001a |
| Nephropathy | |||
| − (%) | 18 (45.0) | 132 (83.5) | <0.001a |
| Proteinuria (%) | 1 (2.5) | 17 (10.8) | 0.052a |
| Chronic renal failure (%) | 21 (52.5) | 9 (5.7) | <0.001a |
aCalculated using the chi-squared test. bCalculated using the Mann–Whitney U test.
cCalculated using the t test. Disability+, patients with ADL disability; Disability−, patients without ADL disability.